+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
543828

Sudarshan Pharma Industries Share Price

 
Stock touched 52W high

 

Sudarshan Pharma Industries live price: ₹39.5. It opened at ₹39 vs previous close ₹38; intraday high/low: ₹40/₹37. The 50 & 200 DMA stand at ₹33.26/₹29.18.

Sudarshan Pharma Industries Performance

  • Today's Low
  • ₹37
  • Today's High
  • ₹40
  • 52 Week Low
  • ₹19
  • 52 Week High
  • ₹40
  • Open Price₹39
  • Previous Close₹38
  • Volume944,000
  • 50 DMA₹33.26
  • 100 DMA₹30.70
  • 200 DMA₹29.18

Sudarshan Pharma Industries Chart

Investment Returns

  • Over 1 Month + 17.77%
  • Over 3 Month + 80.04%
  • Over 6 Month + 56.75%
  • Over 1 Year + 35.83%

Smart Investing Starts Here Start SIP with Sudarshan Pharma Industries for Steady Growth!

Invest Now

Sudarshan Pharma Industries Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 40.8
  • PEG Ratio
  • 0.9
  • Market Cap Cr
  • 951
  • P/B Ratio
  • 6.1
  • Average True Range
  • 1.77
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.5
  • RSI
  • 74.92
  • MFI
  • 73.51

Latest Stock News Updates

Sudarshan Pharma Approves To Raise Rs 1,500 Crore Via Equity Issue

The funds will be raised in one or more tranches, Sudarshan Pharma said in a regulatory filing.

Small-cap stock below 50: Pharma stock jumps 6% from today's low on this acquisition buzz

Small-cap stock below 50: Pharma stock , Sudarshan Pharma lndustries jumps 6% from lows in the stock market today on this acquisition buzz. It plans establish a wholly-owned subsidiary in Poland, a move aimed to broaden its business operations, potentially enhancing investor confidence

Multibagger pharma stock hits a 52-week high after an over 550% rally in 1 year. Do you own?

Sudarshan Pharma Industries' shares increased 5% to a 52-week high of 53.50 on January 7. The company plans to discuss a fundraising strategy in its upcoming board meeting on January 10.

Sudarshan Pharma Industries Financials

Sudarshan Pharma Industries Technicals

EMA & SMA

Current Price
₹39.50
+ 1.01 (2.62%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹36.10
  • 50 Day
  • ₹33.30
  • 100 Day
  • ₹30.70
  • 200 Day
  • ₹29.20

Resistance and Support

38.98 Pivot Speed
  • R3 45.22
  • R2 42.82
  • R1 41.38
  • S1 37.54
  • S2 35.14
  • S3 33.70

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sudarshan Pharma Industries has an operating revenue of Rs. 703.06 Cr. on a trailing 12-month basis. An annual revenue growth of 40% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 15% is good. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 14% and 36% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 9% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 78 which is a FAIR score but needs to improve its earnings, a RS Rating of 92 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 39 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sudarshan Pharma Industries Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-06-18 Issue Of Warrants Inter-alia, to consider 1. Proposal for raising of funds by way of issue of one or more instruments through private placement / preferential issue or such method or combination thereof per share(3%)Final Dividend
2026-05-21 Others (Revised) Inter-alia to consider 1. Approve Migration of listing / trading of the Equity Shares. 2. Approve Postal Ballot Notice & Calendat of events for seekirg approval. 3. Other business matters. per share(3%)Final Dividend
2026-05-15 Others Inter-alia, to consider 1. The proposal for the issuance of Foreign Currency Convertible Bonds, subject to receipt of applicable regulatory and statutory approvals. per share(3%)Final Dividend
2026-04-30 Audited Results
2026-01-28 Quarterly Results
Date Purpose Remarks
2024-11-23 Split Rs.0.00 split from Rs. 10/- to Re. 1/-.

Sudarshan Pharma Industries Shareholding Pattern

57.39%
19.95%
16.42%
6.24%

Sudarshan Pharma Industries FAQs

Sudarshan Pharma Industries share price is ₹39 As on 24 June, 2026 | 19:44

The Market Cap of Sudarshan Pharma Industries is ₹950.6 Cr As on 24 June, 2026 | 19:44

The P/E ratio of Sudarshan Pharma Industries is 40.8 As on 24 June, 2026 | 19:44

The PB ratio of Sudarshan Pharma Industries is 6.1 As on 24 June, 2026 | 19:44

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23